Bin Qu

Dr. Bin Qu

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2014 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
CKCarsten Kummerow
Carsten Kummerow
ESEva C. Schwarz
Eva C. Schwarz
BBBernd Bufe
Bernd Bufe
FZFrank Zufall
Frank Zufall
MHMarkus Hoth
Markus Hoth
BQBin Qu
Bin Qu
Click on the article title to read more.

8 July 2017 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
RSRouven Schoppmeyer
Rouven Schoppmeyer
RZRenping Zhao
Renping Zhao
HCHe Cheng
He Cheng
MHMohamed Hamed
Mohamed Hamed
CLChen Liu
Chen Liu
BQBin Qu
Bin Qu
The actin‐binding protein profilin1 (PFN1) plays a central role in actin dynamics, which is essential for cytotoxic T lymphocyte (CTL) functions. The functional role of PFN1 in CTLs, however still remains elusive. Here, we identify PFN1 as the only member of the profilin family expressed in primary human CD8+ T cells. Using in vitro assays, we find that PFN1 is a negative regulator of CTL‐mediated elimination of target cells. Furthermore, PFN1 is involved in activation‐induced lytic granule (LG) release, CTL migration and modulation of actin structures at the immunological synapse (IS). During CTL migration, PFN1 modulates the velocity, protrusion formation patterns and protrusion sustainability. In contrast, PFN1 does not significantly affect migration persistence and the rates of protrusion emergence and retraction. Under in vitro conditions mimicking a tumor microenvironment, we show that PFN1 downregulation promotes CTL invasion into a 3D matrix, without affecting the viability of CTLs in a hydrogen peroxide‐enriched microenvironment. Highlighting its potential relevance in cancer, we find that in pancreatic cancer patients, PFN1 expression is substantially decreased in peripheral CD8+ T cells. Taken together, we conclude that PFN1 is a negative regulator for CTL‐mediated cytotoxicity and may have an impact on CTL functionality in a tumor‐related context.

17 August 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
RZRenping Zhao
Renping Zhao
XZXiangda Zhou
Xiangda Zhou
EKEssak S. Khan
Essak S. Khan
DADalia Alansary
Dalia Alansary
KFKim S. Friedmann
Kim S. Friedmann
BQBin Qu
Bin Qu
Efficacy of cytotoxic T lymphocyte (CTL)-based immunotherapy is still unsatisfactory against solid tumors, which are frequently characterized by condensed extracellular matrix. Here, using a unique 3D killing assay, we identify that the killing efficiency of primary human CTLs is substantially impaired in dense collagen matrices. Although the expression of cytotoxic proteins in CTLs remained intact in dense collagen, CTL motility was largely compromised. Using light-sheet microscopy, we found that persistence and velocity of CTL migration was influenced by the stiffness and porosity of the 3D matrix. Notably, 3D CTL velocity was strongly correlated with their nuclear deformability, which was enhanced by disruption of the microtubule network especially in dense matrices. Concomitantly, CTL migration, search efficiency, and killing efficiency in dense collagen were significantly increased in microtubule-perturbed CTLs. In addition, the chemotherapeutically used microtubule inhibitor vinblastine drastically enhanced CTL killing efficiency in dense collagen. Together, our findings suggest targeting the microtubule network as a promising strategy to enhance efficacy of CTL-based immunotherapy against solid tumors, especially stiff solid tumors.

11 February 2021 in Biophysical Reviews
Verified
Journal Article
Open access
PDF file
DVDoriane Vesperini
Doriane Vesperini
GMGalia Montalvo
Galia Montalvo
BQBin Qu
Bin Qu
Franziska LautenschlägerFranziska Lautenschläger
Franziska Lautenschläger
The immune system provides our defense against pathogens and aberrant cells, including tumorigenic and infected cells. Motility is one of the fundamental characteristics that enable immune cells to find invading pathogens, control tissue damage, and eliminate primary developing tumors, even in the absence of external treatments. These processes are termed “immune surveillance.” Migration disorders of immune cells are related to autoimmune diseases, chronic inflammation, and tumor evasion. It is therefore essential to characterize immune cell motility in different physiologically and pathologically relevant scenarios to understand the regulatory mechanisms of functionality of immune responses. This review is focused on immune cell migration, to define the underlying mechanisms and the corresponding investigative approaches. We highlight the challenges that immune cells encounter in vivo, and the microfabrication methods to mimic particular aspects of their microenvironment. We discuss the advantages and disadvantages of the proposed tools, and provide information on how to access them. Furthermore, we summarize the directional cues that regulate individual immune cell migration, and discuss the behavior of immune cells in a complex environment composed of multiple directional cues.

5 January 2012 in European Journal of Immunology
Verified
Journal Article
Closed access
PDF file
VPVarsha Pattu
Varsha Pattu
BQBin Qu
Bin Qu
ESEva C. Schwarz
Eva C. Schwarz
BSBettina Strauß
Bettina Strauß
LWLisa Weins
Lisa Weins
MHMarkus Hoth
Markus Hoth

26 August 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
QTQiuqiong Tang
Qiuqiong Tang
THTim Holland-Letz
Tim Holland-Letz
ASAlla Slynko
Alla Slynko
KCKatarina Cuk
Katarina Cuk
FMFrederik Marme
Frederik Marme
BBBarbara Burwinkel
Barbara Burwinkel
DNA methylation array analysis identifies breast cancer associated RPTOR , MGRN1 and RAPSN hypomethylation in peripheral blood DNA DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA